ArticleOncotarget2017

Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.

Manh-Cuong Vo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.